ClinicalTrials.Veeva

Menu

Cosmetic Effects of Topical Acetyl Zingerone

University of California (UC) Davis logo

University of California (UC) Davis

Status

Completed

Conditions

Lipidome
Erythema
Side Effect
Microbiome
Skin Pigment
Wrinkle Appearance

Treatments

Other: Topical cream
Other: Acetyl Zingerone Topical Cream

Study type

Interventional

Funder types

Other

Identifiers

NCT03530787
1161176

Details and patient eligibility

About

Cosmeceuticals are an emerging market within dermatology and the growth of natural products and derivatives of natural products has accelerated in use within the field. Here the investigators aimed to study the microbial and cosmetic effects of Synoxyl AZ, the trade name for topical acetyl zingerone (AZ), a novel compound designed based on Zingerone and curcumin.

Full description

Cosmeceuticals are an emerging market within dermatology and the growth of natural products and derivatives of natural products has accelerated in use within the field. Here the investigators aim to study Synoxyl AZ, the trade name for topical acetyl zingerone (AZ), a novel compound designed based on Zingerone and curcumin.

Both curcumin and Zingerone are from the Zingiberacea family of plants (also known as the ginger family). Both have been widely studied and noted to have antibacterial effects and promote skin health effects. Curcumin has been studied widely in recent years due to various microbial effects. AZ is a derivative that is similar to both Zingerone and curcumin and has been noted to have many different activities including anti-inflammatory, antimicrobial, and antioxidant functions. However, there are no studies looking at how it modulates the skin cosmetically or the superficial microbiome.

The aim of this study was to compare the cosmetic effects of AZ to a vehicle over an 8-week period.

Enrollment

31 patients

Sex

All

Ages

30 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Individuals aged 30-60
  • Healthy subjects

Exclusion criteria

  • Those that have had topical antibiotics within the past 4 weeks
  • Those that have had oral antibiotics within past 4 weeks
  • Those who have used systemic isotretinoin in the last 6 months
  • Those with a known allergy to members of the ginger family
  • Current smokers OR 20 pack-year history of smoking OR Have smoked within the past 3 years
  • Pregnant women
  • Prisoners
  • Those who have had any change to their hormonal birth control regimen in the last 4 weeks.
  • Those with visible signs in the area of application of or on active treatment for cystic acne, eczema, seborrheic dermatitis, papulopustular rosacea at investigator discretion
  • Those who have had a recent surgical or cosmetic procedure in the last 3 months that can affect facial wrinkles or facial hyperpigmentation, such as botulinum toxin injections, chemical peels, laser based therapies to the face, or face lift surgeries at investigator discretion

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

31 participants in 2 patient groups, including a placebo group

Acetyl Zingerone Group
Active Comparator group
Description:
This group was given the topical with the active acetyl zingerone agent.
Treatment:
Other: Acetyl Zingerone Topical Cream
Control Group
Placebo Comparator group
Description:
This group was given the topical without the active acetyl zingerone agent and just the carrier lotion.
Treatment:
Other: Topical cream

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems